Drug Index

CYRAMZA

Generic: RAMUCIRUMAB

Review priority: STANDARD Marketing status: Prescription

Structured Monograph

Approval overview CYRAMZA is listed in Drugs@FDA under application 125477 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient RAMUCIRUMAB Form and strength INJECTABLE;INJECTION - 100MG/10ML Sponsor ELI LILLY AND CO Submission history Latest submission status date: 2025-08-19 00:00:00. Submission type: SUPPL.